Rankings
▼
Calendar
CGEM Q2 2019 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$841M
Q2 2019 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-5.94
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$8,500
← FY 2019
All Quarters
Q3 2019 →
